Molecular You
Molecular You is a pioneer in predictive, preventative, and precision health, providing advanced molecular analysis to empower individuals and healthcare providers with actionable health insights. Founded in 2014 as a spin-off from the Personalized Medicine Initiative in Vancouver, BC, the company leverages cutting-edge proteomics, metabolomics, and AI to analyze over 250 blood-based biomarkers. Their mission is to make molecular medicine simple, accessible, and impactful, enabling early detection of disease risks and supporting personalized, data-driven health decisions. Molecular You serves both clinics and individuals, offering comprehensive health assessments, personalized action plans, and ongoing progress tracking to foster proactive, transparent, and preventative care. The company’s platform is rooted in rigorous scientific validation, peer-reviewed research, and advanced multi-omic analysis, setting a new standard for precision health and population health management. Molecular You’s unique systems biology approach analyzes interconnected pathways—such as metabolic, cardiovascular, immune, neurological, and hormonal health—providing a holistic view of health that goes far beyond traditional lab tests. Their direct-to-consumer platform enables at-home blood draws and digital health dashboards, and their Action Plan translates biomarker data into tailored, science-backed recommendations for diet, supplements, and lifestyle. The platform’s comprehensive biomarker coverage and AI-driven insights empower both patients and providers to detect and address health concerns long before symptoms arise.
Molecular You
#307-788 Beatty Street, Vancouver, British Columbia, Canada V6B 2M1
What We Do
A single blood test analyzing over 250 biomarkers to assess risks across 26+ health areas, including cardiovascular, metabolic, inflammatory, cognitive, and behavioral health. The platform delivers personalized, AI-driven action plans and tracks progress over time for both clinics and individuals. The test covers a wide array of biological pathways and disease risks, such as pre-diabetes, type 2 diabetes, cardiovascular disease, atherosclerosis, liver disease, autoimmune conditions, and more, by quantifying key proteins, metabolites, and other molecular markers. The platform’s biomarker coverage includes pathways such as beta-oxidation of fatty acids, coagulation, complement cascade, glycolysis-gluconeogenesis, hormone binding and transport, Krebs cycle, lipid metabolism, neurotransmitter metabolism, oxidative stress, protein metabolism, and the urea cycle.
A centralized digital platform for clinics to access aggregated biomarker results, health scores, and personalized recommendations. Integrates with EHR systems and supports streamlined patient management and engagement.
Comprehensive biomarker analysis for clinics, including specialized solutions for behavioral health and functional medicine. Enables early detection of disease risks, personalized action plans, and ongoing patient monitoring.
Advanced biomarker testing for behavioral health clinics, analyzing pathways related to mental health (serotonin, dopamine, HPA axis, gut health) to inform personalized, data-driven care and reduce drug dependence.
Holistic molecular testing for functional medicine clinics, covering 250+ biomarkers across 15 health scores and 12 biological pathways. Supports root-cause analysis and personalized interventions for chronic and complex conditions.
Direct-to-consumer health assessments that analyze 250+ biomarkers, providing personalized reports, diet, supplement, and exercise recommendations, and ongoing support for health optimization and disease prevention.
Application Area
Psychological and Cognitive Health and Performance
Show More (1)Diagnostics
Show More (1)Digital Health Technologies
Show More (5)Drugs
Key People
CEO
CSO + President, Co-founder
Chief Informatics Officer, Co-founder
Chief Medical Officer
Chief Lab Analytics Officer, Co-founder
News & Updates
Molecular You’s platform enabled the early detection of stage 1 pancreatic cancer in a symptom-free patient, leading to successful intervention and demonstrating the real-world, life-saving potential of multi-omic biomarker analysis.
Received for advancing personalized health technologies in collaboration with The Metabolomics Innovation Centre (TMIC).
Recognized for commitment to innovative health solutions in the longevity sector.
Explains how comprehensive biomarker testing provides a multidimensional view of health, supporting early intervention and personalized care.
Discusses how stress impacts biological aging, with biomarkers providing insight into physiological changes and health risks.
Explores the role of blood-based biomarkers in early detection and monitoring of autoimmune diseases, supporting more personalized and timely interventions.